Analyzing the trends and forecasting Global Lung Cancer Therapeutics Analyzing the trends and forecasting Global Lung C | Page 7

9.1.1 Overview
9.1.2 Product Analysis
9.1.3 Strategic Evaluation and Operations
9.1.4 Financial analysis
9.1.5 Legal issues
9.1.6 Recent Developments
9.1.7 SWOT analysis
9.1.8 Analyst View
9.2 Hoffman-La Roche
9.3 Pfizer Inc.
9.4 GlaxoSmitKline
9.5 Eli Lilly and Company
9.6 AstrazenecaPlc
9.7 Sanofi-Aventis
9.8 Agennix AG
10. Competitive Landscape
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations and Joint Ventures
10.4 New Product Launches
11. Expert Opinions
11.1 Market Outlook
11.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures